Skip to content

Benefit of Systematic Proposition of Nicotine Substitution for Patients Undergoing Surgery

Benefit of a Systematic Proposition of Nicotine Replacement Therapy Preoperatively for Patients Undergoing Planned Surgery and With Tobacco or Cannabis Addiction, Regardless of the Intention to Quit

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04572646
Acronym
PATCHIR
Enrollment
20
Registered
2020-10-01
Start date
2020-08-24
Completion date
2022-05-31
Last updated
2023-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

postoperative complication, nicotine replacement therapy, exhaled carbon monoxide level

Brief summary

Smoking is associated with a higher rate of surgical complications. For example, in orthopedics, the risk of complications is 31% in smokers against 5% in non-smokers. The management of this addiction is recommended and particularly interesting in scheduled surgery, because it allows smoking cessation well before the procedure. However, for patients who cannot consider this smoking cessation, the mere information of the risk cannot be sufficient and a real strategy must be constructed and evaluated. Currently, studies results indicate that a patient reducing the number of smoked cigarettes will unconsciously modify their smoking behaviour to obtain the usual nicotine level, this effect is called self-titration. Conversely, nicotine replacement while continuing consumption could induce an improvement in smoking behaviour, therefore less intoxication which would be beneficial in terms of reduction of post-operative complications. This study seeks to assess the effectiveness of a systematic proposition of nicotine replacement therapy (NRT) in regular smokers. Tobacco addiction specialists have demonstrated that intoxication and dependence are well correlated with the exhaled carbon monoxide (CO) level, so this measurement will be used in addition to the patient's interview.

Interventions

OTHERNRT proposition and exhaled CO measurement

Nicotine replacement therapy is proposed to every patient included in the study. Whether the patient accepts the therapy or not, exhaled carbon monoxide is measured at the preoperative consultation (about 15 days before surgery) and the day of surgery by a nurse. These two measures are compared to assess efficacy of nicotine replacement therapy.

Sponsors

Groupe Hospitalier Mutualiste de Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who smokes at least one cigarette or cannabis joint per day, every day * Patient received for nurse consultation at least 48 hours before surgery * Patient planned to undergo surgery, with entry the day of surgery and 1 day of post-operative hospitalisation * Patient in physical capacity and willing to undergo exhaled carbon monoxide measurement * For patients with one of the following chronic diseases: diabetes, Chronic Obstructive Pulmonary Disease, glucose intolerance, hemolytic anemia, asthma and dilation of the bronchi, these diseases must be stable * Signature of the specific study informed consent * Patient affiliated or beneficiary of social security system

Exclusion criteria

* Inability to submit to study follow-up for geographic, social or psychological reasons * Patient already included in an interventional clinical research protocol * Patients protected by French law from clinical research inclusion (pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation) * Patient using nicotine substitutes before the nurse consultation * Alcohol consumption six hours before the exhaled carbon monoxide measurement

Design outcomes

Primary

MeasureTime frame
Efficacy of a systematic proposition of nicotine replacement therapy, regardless of the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitorAt inclusion, and before surgery

Secondary

MeasureTime frameDescription
Effect of nicotine replacement therapy on the type of analgesics administratedAt inclusion, before surgery, and 2 days after surgery
Effect of nicotine replacement therapy on the duration of analgesics administratedAt inclusion, before surgery, and 2 days after surgery
Number of patients who refuse nicotine replacement therapyAt inclusion
Number of smoking cessations2 days after surgery
Efficacy of a systematic proposition of nicotine replacement therapy, depending on the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitorAt inclusion, and before surgerySubgroup analysis of the primary endpoint according to predefined groups
Effect of nicotine replacement therapy on the dose of analgesics administratedAt inclusion, before surgery, and 2 days after surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026